Fortress Biotech, Inc. — Form 8-K
Filed October 1, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 5/100
What the filing says
Fortress Biotech filed an 8-K on September 30, 2026 disclosing other events under Item 8.01. The filing documents do not specify the content of the disclosed event, counterparties, dollar amounts, share counts, or dates beyond the filing date. No material transaction, agreement, or business change is detailed in the available filing metadata.
Why this rating
Filing is procedural disclosure with no disclosed material facts, dollar figures, or business impact specified. Routine SEC filing for a $43.7M company.
Extracted items
See more from October 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.